Company: ARTL
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001640334-25-000335
Chunk: 1203

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 8
Chunk 1203
---
 as it continues to conduct research and development related activities through all stages of product development and clinical trials and subsequently seek approval from the respective regulatory authorities. The Company’s CODM utilizes cash forecast models to determine the Company’s investment in the life sciences segment. These models are reviewed regularly to monitor the Company’s operating results and performance and compared to the Company’s cash-based forecasts.   Year ended   December 31,   2024  2023        General and administrative      Employee and director compensation $1,173  $1,091 Stock-based compensation  501   710 Professional fees  1,133   1,101 Other general and administrative (a)  1,308   1,332       Total general and administrative $4,115  $4,234   Year ended   December 31,   2024  2023        Research and development      Employee compensation $1,166  $983 Stock-based compensation  317   310 Professional fees  5,169   4,531 Research and development tax credits (b)  (1,349)  (1,206)Other research and development (c)  690   1,078       Total research and development $5,993  $5,696   (a)Consists of sales and marketing, investor relations, travel and other office expenses.  (b)Reflects tax credits from United Kingdom government recorded directly as a reduction of research and development expense upon receipt.  (c)Consists of supplies and other items used in research and development activities.  

NOTE 4 – RELATED PARTY TRANSACTIONS During the years ended December 31, 2024, and 2023, a company owned by the Senior Vice President, European Operations, provided consulting services totaling $9 and $12, respectively. As of December 31, 2024, and 2023, there was $1 and $2, outstanding, respectively. During the years ended December 31, 2024, and 2023, a company significantly influenced by a director of a subsidiary of the Company provided professional services totaling $100 and $135, respectively. As of December 31, 2024, and 2023, there was $36 and $5 outstanding, respectively. During the